These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1063 related articles for article (PubMed ID: 23913554)

  • 1. The interplay between HPV and host immunity in head and neck squamous cell carcinoma.
    Andersen AS; Koldjaer Sølling AS; Ovesen T; Rusan M
    Int J Cancer; 2014 Jun; 134(12):2755-63. PubMed ID: 23913554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic and local human papillomavirus 16-specific T-cell immunity in patients with head and neck cancer.
    Heusinkveld M; Goedemans R; Briet RJ; Gelderblom H; Nortier JW; Gorter A; Smit VT; Langeveld AP; Jansen JC; van der Burg SH
    Int J Cancer; 2012 Jul; 131(2):E74-85. PubMed ID: 22020783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD8
    Masterson L; Lechner M; Loewenbein S; Mohammed H; Davies-Husband C; Fenton T; Sudhoff H; Jani P; Goon P; Sterling J
    Eur J Cancer; 2016 Nov; 67():141-151. PubMed ID: 27669501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of HPV Infection on the Immune System in Oropharyngeal and Non-Oropharyngeal Squamous Cell Carcinoma: A Systematic Review.
    Lechien JR; Seminerio I; Descamps G; Mat Q; Mouawad F; Hans S; Julieron M; Dequanter D; Vanderhaegen T; Journe F; Saussez S
    Cells; 2019 Sep; 8(9):. PubMed ID: 31510065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peritumoral cuffing by T-cell tumor-infiltrating lymphocytes distinguishes HPV-related oropharyngeal squamous cell carcinoma from oral cavity squamous cell carcinoma.
    Poropatich K; Hernandez D; Fontanarosa J; Brown K; Woloschak G; Paintal A; Raparia K; Samant S
    J Oral Pathol Med; 2017 Nov; 46(10):972-978. PubMed ID: 28632936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus (HPV) 16 and the prognosis of head and neck cancer in a geographical region with a low prevalence of HPV infection.
    López RV; Levi JE; Eluf-Neto J; Koifman RJ; Koifman S; Curado MP; Michaluart-Junior P; Figueiredo DL; Saggioro FP; de Carvalho MB; Kowalski LP; Abrahão M; de Góis-Filho F; Tajara EH; Waterboer T; Boffetta P; Brennan P; Wünsch-Filho V
    Cancer Causes Control; 2014 Apr; 25(4):461-71. PubMed ID: 24474236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DETECTION OF HUMAN PAPILLOMA VIRUS IN HEAD AND NECK SQUAMOUS CELL CARCINOMAS: A LITERATURE REVIEW.
    Jelihovschi I; Bidescu AC; Tucaliuc SE; Iancu LS
    Rev Med Chir Soc Med Nat Iasi; 2015; 119(2):502-9. PubMed ID: 26204659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16-driven oropharyngeal squamous cell carcinoma.
    Holzinger D; Wichmann G; Baboci L; Michel A; Höfler D; Wiesenfarth M; Schroeder L; Boscolo-Rizzo P; Herold-Mende C; Dyckhoff G; Boehm A; Del Mistro A; Bosch FX; Dietz A; Pawlita M; Waterboer T
    Int J Cancer; 2017 Jun; 140(12):2748-2757. PubMed ID: 28316084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated intrinsic cancer stem cell population in human papillomavirus-associated head and neck squamous cell carcinoma.
    Zhang M; Kumar B; Piao L; Xie X; Schmitt A; Arradaza N; Cippola M; Old M; Agrawal A; Ozer E; Schuller DE; Teknos TN; Pan Q
    Cancer; 2014 Apr; 120(7):992-1001. PubMed ID: 24382806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-infiltrating B cells affect the progression of oropharyngeal squamous cell carcinoma via cell-to-cell interactions with CD8
    Hladíková K; Koucký V; Bouček J; Laco J; Grega M; Hodek M; Zábrodský M; Vošmik M; Rozkošová K; Vošmiková H; Čelakovský P; Chrobok V; Ryška A; Špíšek R; Fialová A
    J Immunother Cancer; 2019 Oct; 7(1):261. PubMed ID: 31623665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor activity of human papillomavirus type 16 E7-specific T cells against virally infected squamous cell carcinoma of the head and neck.
    Albers A; Abe K; Hunt J; Wang J; Lopez-Albaitero A; Schaefer C; Gooding W; Whiteside TL; Ferrone S; DeLeo A; Ferris RL
    Cancer Res; 2005 Dec; 65(23):11146-55. PubMed ID: 16322265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A beneficial tumor microenvironment in oropharyngeal squamous cell carcinoma is characterized by a high T cell and low IL-17(+) cell frequency.
    Punt S; Dronkers EA; Welters MJ; Goedemans R; Koljenović S; Bloemena E; Snijders PJ; Gorter A; van der Burg SH; Baatenburg de Jong RJ; Jordanova ES
    Cancer Immunol Immunother; 2016 Apr; 65(4):393-403. PubMed ID: 26899388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination Expectations in HNSCC.
    Syrjänen S; Rautava J
    Recent Results Cancer Res; 2017; 206():257-267. PubMed ID: 27699546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immune System in Patients with Head and Neck Carcinoma].
    Partlová S; Bouček J; Kloudová K; Zábrodský M; Špíšek R; Fialová A
    Klin Onkol; 2015; 28 Suppl 4():4S86-94. PubMed ID: 26647896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus (HPV) and oropharyngeal squamous cell carcinoma.
    Dalianis T
    Presse Med; 2014 Dec; 43(12 Pt 2):e429-34. PubMed ID: 25455638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
    Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
    Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
    Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N
    Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPV Integration in Head and Neck Squamous Cell Carcinomas: Cause and Consequence.
    Speel EJ
    Recent Results Cancer Res; 2017; 206():57-72. PubMed ID: 27699529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased radiosensitivity of HPV-positive head and neck cancers: Molecular basis and therapeutic perspectives.
    Mirghani H; Amen F; Tao Y; Deutsch E; Levy A
    Cancer Treat Rev; 2015 Dec; 41(10):844-52. PubMed ID: 26476574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Immunocompetent Mouse Model of HPV16(+) Head and Neck Squamous Cell Carcinoma.
    Carper MB; Troutman S; Wagner BL; Byrd KM; Selitsky SR; Parag-Sharma K; Henry EC; Li W; Parker JS; Montgomery SA; Cleveland JL; Williams SE; Kissil JL; Hayes DN; Amelio AL
    Cell Rep; 2019 Nov; 29(6):1660-1674.e7. PubMed ID: 31693903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.